Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tang Wang Prescription for Diabetic Non-proliferative Retinopathy
NCT03025399Phase 1Unknown
- Start
- Feb 2017
- Primary completion
- May 2019
- Modality
- HM (Herbal Medicine)
01
Overview
Phase 1, randomised, double-blind trial comparing Tangwang Prescription with Placebo (2 arms). Primary endpoint: Changes of degree of retinal microvascular lesions at 48 weeks. Status: unknown.
02
Drugs
Tangwang
Beyond the preview
Go deeper on NCT03025399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03025399.